Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. Society for Epidemiologic Research (SER), Seattle WA, June 2017.
Society for Epidemiologic Research (SER) (2017)
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
June, 2017
Citation Information
Philip Mease and et.al.. "Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. Society for Epidemiologic Research (SER), Seattle WA, June 2017." Society for Epidemiologic Research (SER) (2017)
Available at: http://works.bepress.com/philip-mease/285/